Back to results
US 2008/0176902 A1Published application
Salt III
AssigneeAstraZeneca AB
InventorsJulien Giovannini, Bo-Goran Josefsson
Life of this patent
Estimating the term…
Abstract
The invention provides N-{2-[((2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methyl-propyl)oxy]-4-hydroxyphenyl}acetamide hemi-fumarate or a solvate thereof, pharmaceutical compositions containing the salt or solvate and use of the salt or solvate in therapy.
Claims11
A compound being N-{2-[((2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl)oxy]-4-hydroxyphenyl}acetamide hemi-fumarate or a solvate thereof.
7-10. (canceled)
Dependencies are inferred from the claim text.